# FDA Inspection 1018966 - Biomat USA, Inc - July 20, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/b10ad0d5-e07d-4ef4-949d-33d7d65cacff
Source feed: FDA_Inspections

> FDA Inspection 1018966 for Biomat USA, Inc on July 20, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018966
- Company Name: Biomat USA, Inc
- Inspection Date: 2017-07-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1220609 - 2023-10-13](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/6f0dde14-d122-4d13-b89b-739f5b442880)
- [FDA Inspection 1118061 - 2020-02-11](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/1ee54935-b374-4dbd-9c75-ca97263daa21)
- [FDA Inspection 938657 - 2015-08-18](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/16c60444-139d-420f-8c73-cd2355385401)
- [FDA Inspection 849952 - 2013-09-25](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/fbe14e7a-1bc3-4e4c-8177-caba58f75bab)
- [FDA Inspection 721933 - 2011-05-05](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/368c8599-9aae-4480-aa2b-19695510c4ff)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/5468316d-22c2-45ea-919a-4b2a58e3eaf7

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d